Back to 
RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P.
TVTXShowing 7 of 17 quarters
Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in TRAVERE THERAPEUTICS INC
No. RA Capital Management exited its TVTX (Travere Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 746,841 shares worth $22.2M. RA Capital Management already held TVTX in its Q4 2020 13F, the earliest on record, and held it in 14 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$20M
Total Shares Change
-1.2M
Quarter-by-Quarter History
Other major holders of TVTX: Jupiter Topco LLC, BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.